Secondary prevention of embolic stroke of undetermined source
10.3760/cma.j.issn.1673-4165.2021.03.010
- VernacularTitle:栓子源不明的栓塞性卒中的二级预防
- Author:
Xinyi ZHU
;
Wusheng ZHU
;
Minmin MA
- From:
International Journal of Cerebrovascular Diseases
2021;29(3):210-215
- CountryChina
- Language:Chinese
-
Abstract:
Antiplatelet therapy is commonly used for the secondary prevention of embolic stroke of undetermined source (ESUS). However, the embolic source of ESUS is extremely heterogeneous, and the effect of antithrombotic therapy is different. This article describes the etiology and secondary prevention research progress of ESUS, in order to provide reference for clinical diagnosis and treatment.
